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Background/aim: Our research focused on the identification of easily available and sensitive markers for early prediction of acute
kidney allograft rejection (AR). We aimed to investigate the association between neutrophil-to-lymphocyte ratio (NLR) and AR in
kidney transplant patients.
Materials and methods: The medical records of 51 kidney transplant patients [12 female/39 male; median age of 32 (IQR: 24–44) years]
were evaluated retrospectively. We considered a cut-off value of >2.5 as high NLR.
Results: A total of 22 biopsy-proven AR patients and 29 controls were evaluated. The AR group had a higher NLR compared to the
controls (P < 0.001). NLR levels over 2.5 [95% CI: 54.88 (9.96–302.3), P < 0.001] were significantly associated with AR in univariate
analysis. The NLR levels were the only significant factor associated with AR in multivariate models, in model 1 (adjusted by age and
sex) [95% CI: 114 (11.1–1175), P < 0.001], and in model 2 (adjusted by steroid dosage, uric acid, and NLR) [95% CI: 4.60 (1.59–29.3),
P = 0.004].
Conclusion: Our data showed that higher NLR values (>2.5) are associated with AR in kidney transplant patients, leading to the
conclusion that NLR might be an easily available and useful marker option for detection of AR in this patient population.
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1. Introduction
Kidney transplantation is the best therapeutic option for
end-stage renal disease (ESRD) patients. Health-related
quality of life and patient survival are assumed to improve
with kidney transplantation compared to conventional
hemodialysis (1,2). Acute kidney allograft rejection
(AR) is the most important risk factor for graft loss
after transplantation, and some kidneys do not recover
function even with intense antirejection therapy. Many
other variables contribute significantly to the chances of
rejection of kidney transplants, such as donor source, age,
sex, creatinine level, blood group, Rh type, waiting time,
duration of hospitalization, and vascular complications
(3,4). The use of a large array of immunosuppressant drugs
reduced the incidence of AR episodes, but long-term graft
survival is still insufficient in this patient population.
The neutrophil-to-lymphocyte ratio (NLR) was first
described in 1967 (5) and was reported as an easy metric
to assess inflammatory state. There are several studies that

give evidence for its efficacy as a predictor of prognosis and/
or mortality in various inflammatory states, such as cancer
(6,7), acute coronary syndrome (8–10), and infections and
postoperative complications (11–13). Numerous previous
studies have demonstrated that an increase in NLR is
associated with delayed and poor kidney graft function
(14–16).
In this retrospective study, we aimed to evaluate the
association between NLR and acute kidney allograft
rejection, which is an important inflammatory state in
kidney transplant patients.
2. Materials and methods
2.1. Study design and patients
We retrospectively investigated kidney transplant patients
who were under follow-up treatment from September 1996
to January 2018 at the Yüksek İhtisas University Faculty
of Medicine and Gazi University Faculty of Medicine.
This study was conducted according to the Helsinki
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Declaration and the institutional review board of each
university approved the study protocol. Inclusion criteria
were receiving an ABO-compatible first-time kidney
transplantation and medical chart achievability. Exclusion
criteria were being under the age of 18, receiving a second
transplantation, any proven history of cardiovascular
disease or cancer, any diagnosis of BK nephropathy or
CMV positivity, obesity, and active systemic, urinary, or
local infection proven by a culture during the rejection.
We also excluded patients who were not using steroids
to eliminate the effect of steroids on neutrophil and
lymphocyte distribution and to provide homogeneity for
the population. The immunosuppression protocol used
at our institutions consists of an antithymocyte globulin
and methylprednisolone induction regimen, followed by
maintenance therapy with mycophenolate mofetil/sodium
or azathioprine, prednisolone, and a calcineurin inhibitor
(tacrolimus or cyclosporine).
Medical records were reviewed to find the data for
the patients’ medical history, age, sex, and kidney biopsy
pathology reports during AR. Acute rejection was defined
by an increase of creatinine of 30% above baseline that was
not attributable to any other causes, and AR was detected
via Banff criteria by allograft biopsy in all cases (17).
2.2. Laboratory data
NLR was calculated with the formula of neutrophil count
divided by lymphocyte count. We used blood drawn
on the day of the application to the clinic for the acute
rejection group and on the last outpatient clinic visit day
for the control group. Different values of NLR are used in
the literature in different disease states. Currently there is
no universally accepted reference value, but a ratio above
3 is accepted as a high value in some disease states. In our
study, serial receiver operating characteristic (ROC) curve
analysis of NLRs revealed the 75th quartile (>2.5) to be
the most sensitive and specific determinant of AR, leading
us to consider values of 2.5 or greater as elevated. We
used age-matched kidney transplant patients who had no
rejection episode as a control group. We also retrospectively
obtained serum biochemistry results, uric acid levels, and
erythrocyte sedimentation rates. All immunosuppressive
regimens were noted.
2.3. Statistical analysis
All collected data were analyzed with SPSS 24.0 for Mac
(IBM Corp., Armonk, NY, USA). P < 0.05 was considered
statistically significant. All comparison analyses were
performed by nonparametric tests due to restricted sample
size. Characteristics were compared using the Wilcoxon
rank sum test for baseline continuous variables and the
chic-square test for categorical variables. Spearman’s
test was used for the detection of correlation between
variables. The ROC curve was calculated and the area
under the curve (AUC) was analyzed for determination
of the cut-off value of NLR. Results were expressed as
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median and interquartile range (IQR). Binary logistic
regression analysis was used to investigate factors affecting
AR. Because of the limitation of our sample size and to
avoid overfitting, 3 independent variables were included in
regression analyses in multivariate models.
3. Results
We included the results of 51 kidney transplant patients
who matched our inclusion/exclusion criteria in our
analysis. Of those patients, 9 received deceased and
42 received living donor kidney transplantation. All
patients in the study groups received a standardized
immunosuppressive regimen consisting of calcineurin
inhibitors and mycophenolate mofetil/sodium or
azathioprine and steroids. Acute allograft rejection
occurred in 22 of those subjects (41%). 21 experienced
acute cellular rejection, and 1 experienced antibodymediated rejection. The median time in the AR group
between renal transplantation and acute rejection was 7.5
(0.25–193) months. The median time of required followup was 8 (3–25) months for the AR group and 25 (8–60)
months for the control group. Characteristics of the study
population are provided in Table 1.
Comparisons of the demographics and clinical features
between the AR and control groups are summarized in
Table 2. The patients were similar in terms of age, sex,
and laboratory assessments of baseline creatinine, white
blood cell count, and erythrocyte sedimentation rates. The
median serum uric acid level was statistically significantly
higher in the AR group (P = 0.043). There was 1 patient
with diabetes mellitus in the control group but none in the
AR group, and the control group had more hypertensive
patients than the AR group.
The median NLR level was statistically significantly
higher in the AR group, with a median of 4.06 (3.11–7.03)
in the AR group versus a median of 1.24 (1.08–1.57) in the
control group (P < 0.001) (Figure).
Univariate binary logistic regression analysis was
performed to analyze each factor affecting AR. Serum uric
acid levels [95 % CI: 1.588 (1.014–2.486), P = 0.043] and
NLR >2.5 [95% CI: 54.88 (9.96–302.3), P < 0.001] were
statistically significantly associated with AR. Also, having
living donor transplantation seemed to reduce the chances
of rejection with marginal statistical significance [95% CI:
0.125 (0.014–1.089), P = 0.06] (Table 3). For multivariate
analysis, we created 2 models, each with a maximum of
3 independent variables due to the restricted sample
size. Only NLR was statistically significantly associated
with AR [95% CI: 114 (11.1–1175), P < 0.001] in the
first multivariate model (adjusted by age and sex). The
statistically significant association between serum uric
acid level and AR disappeared in this model (Table 3).
The second model was adjusted by steroid dosage, serum
uric acid level, and NLR. In this model, steroid dosage
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Table 1. Characteristics of complete study population.
Variables

n = 51

Age, years, median (IQR)

32 (24–44)

Sex, male / female

39 / 12 (76.5% / 23.5%)

Donor type, deceased / living

9 / 42 ( 17.6% / 82.4%)

Median time of follow-up, months, median (IQR)

14 (4–48)

Diabetes, negative / positive

50 / 1 (98% / 2%)

Hypertension, negative / positive

44 / 7 (86.3% / 13.7%)

Serum creatinine, mg/dL, median, (IQR)

1.2 (1–1.4)

White blood cells, mm , median (IQR)

8630 (6400–11000)

Uric acid level, mg/dL, median (IQR)

6.1 (5.2–7.4)

ESR, mm/h, median (IQR)

26.5 (12.8–44.8)

NLR, median (IQR)

1.93 (1.2–3.63)

3

IQR: Interquartile range, ESR: erythrocyte sedimentation rate, NLR: neutrophil-tolymphocyte ratio.
Table 2. Comparison of demographical characteristics and biochemical parameters in study subgroups.
Variables

AR
(n = 22)

Control
(n = 29)

P-values

Age, years, median (IQR)

30 (24–38)

35 (27–47)

0.105

Sex, male / female (n)

19 / 3

20 / 9

0.192

Donor type, deceased / living (n)

1 / 21

8 / 21

0.06

Median time of follow-up, months, median (IQR)

8 (3–25)

25 (8–60)

0.05

Diabetes, negative / positive

22 / 0

28 / 1

-

Hypertension, negative / positive (n)

21 / 1

23 / 6

0.550

Creatinine, mg/dL, median (IQR)

1.2 (1.0–1.5)

1.1 (1.4–0.9)

0.307

White blood cells, mm , median (IQR)

9700 (6857–12800)

7500 (6345–10250)

0.223

Uric acid level, mg/dL, median (IQR)

6.9 (5.4–8.1)

5.8 (4.8–6.8)

0.043

ESR, mm/h, median (IQR)

30 (24–45)

22 (11–49)

0.531

NLR, median (IQR)

4.06 (3.11–7.03)

1.24 (1.08–1.57)

<0.001

3

IQR: Interquartile range, ESR: erythrocyte sedimentation rate, NLR: Neutrophil-to-lymphocyte ratio.

was included to exclude a possible effect on NLR. We also
checked the association between steroid dosage and NLR
to determine the confounder effect (interaction) for model
2 and found no statistically significant association between
steroid dosage and NLR [95% CI: 0.96 (–2.39 to 2.49), P
= 0.96]. The second multivariate model revealed that only
NLR was statistically significantly associated with AR
[95% CI: 4.60 (1.59–29.3), P = 0.004] (Table 3).
4. Discussion
In this study, we retrospectively examined kidney
transplant patients who had AR and analyzed the

association with their NLR levels obtained on the day of
application to the clinic. We also included age-matched
control patients who had not experienced AR in our
analysis and found that the NLR in the AR group was
significantly higher compared to the control group. Both
univariate and multivariate analyses showed that NLR of
>2.5 was statistically significantly associated with AR.
The NLR is an inflammatory marker that is inexpensive
and easily available in routine clinical practice. There are
several reports in the literature providing evidence that
NLR is strongly associated with morbidity or mortality
in several inflammatory conditions such as cancer and
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Figure. Comparison of NLR values between acute kidney rejection group and
controls: the median NLR level was statistically significantly higher in AR group [4.06
(3.11–7.03) in AR group versus 1.24 (1.08–1.57) in control group (P < 0.001)].
Table 3. Determinants of acute kidney rejection (univariate and multivariate
regression analysis).
Univariate model
Variables

Βeta coefficient
(confidence interval)

P-values

Age, years

1.04 (0.99–1.09)

0.118

Sex, male

0.35 (0.08–1.49)

0.157

Donor type, living

0.125 (0.014–1.089)

0.06

Baseline creatinine, mg/dL

2.526 (0.578–11.032)

0.218

ESR, mm/h

1.015 (0.976–1.056)

0.455

Uric acid, mg/dL

1.588 (1.014–2.486)

0.043

NLR, >2.5

54.88 (9.96–302.3)

<0.001

Uric acid, mg/dL

1.547 (0.961–2.488)

0.072

NLR, >2.5

114 (11.1–1175)

<0.001

Uric acid, mg/dL

2.563 (0.857–7.665)

0.092

Steroid dose, mg

1.294 (0.937–1.788)

0.118

NLR, >2.5

4.601 (1.593–13.293)

0.004

Multivariate model 1*

Multivariate model 2**

ESR: Erythrocyte sedimentation rate, NLR: neutrophil-to-lymphocyte ratio.
*Model 1: Adjusted by age and sex.
**Model 2: Mixed case model (adjusted by steroid dosage, uric acid, NLR).
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cardiovascular disease, as well as being a predictor for
infectious and postoperative conditions (7,11,13). NLR
levels were positively correlated with inflammatory
cytokines in ESRD patients (18). Another study showed
that kidney transplant patients had a higher NLR than
healthy subjects (19) and concluded that the higher values
were due to the ongoing inflammation in these patients.
A prospective study by Cankaya et al. also reported that
mean NLR levels were improved at the first year after
transplantation but did not reach the levels found in
healthy controls, which is further evidence for chronic
inflammation as permanent in kidney transplantation
(15).
AR is the major cause of graft dysfunction in these
patients. Some of the patients do not recover even with
high-dose antirejection treatment. Most AR episodes
are overlooked by both clinicians and patients, since
they are mostly asymptomatic, but even if this is the case
AR episodes have a negative impact on long-term graft
survival. It is important to use an easily applicable marker
for both the prediction and early detection of AR for this
population. A rise in serum creatinine is an important
and widely used laboratory test for predicting AR, but
creatinine increases indicate significant histological
damage in the kidney, which is a reflection of the late
course of the rejection episode.
Our results present favorable findings regarding
using NLR as a simple, easily available, inexpensive
marker for the assessment and prediction of AR. An
NLR level above 2.5 appears to be a sensitive and specific
predictior of AR, according to ROC curve analysis. Both
univariate and multivariate logistic regression analysis
found it independently associated with AR. We believe
the increase in NLR in AR patients was unrelated to
corticosteroid dosage, because all the patients were using
the same maintenance dosage and our interaction analysis
did not show any significant association as a confounder
effect on the prediction model.
Halazun et al. also found that elevated preoperative
NLR levels were associated with a higher risk of
developing delayed graft function, another state that
has a shared casual mechanism with AR episodes, after
kidney transplantation (16). They concluded that the
preoperative active inflammatory response that was
detected by higher NLR levels might affect the immediate
graft function. They found that NLR over 3.5 acted as

a predictor for delayed graft function. However, in our
study, patients with NLR over 2.5 were more likely to
develop AR. There is no universal cut-off level for NLR
values; most studies have reported the levels according
to the median and higher quartile. A study from a
nongeriatric and healthy population reported that a
normal value for NLR is between 0.78 and 3.58 (20). In
other disease states such as cancer, and in cardiovascular
and surgical patients, NLR values over 3.5 were accepted
as a prediction value for each disease (21,22). NLR
over 2.5 in heart transplantation and over 3.5 in kidney
transplantation were found as predictors for RRT and
graft survival in several studies (16,23). We found that
the NLR cut-off value of 2.5 has 90% specificity and 60%
sensitivity for detection of AR.
There are several limitations of our study. First, the
small sample size impedes generalizability of results. The
retrospective design limits our interpretation of causality.
A single measurement of NLR might not accurately
reflect the relationship over time. Future studies that
obtain serial changes of NLR would be useful to clarify to
role of NLR in the follow-up of AR.
We still believe that NLR is a practical marker in both
inpatient and outpatient settings, and the accumulation
of studies reporting the usefulness of practical and
inexpensive markers for either diagnosis or followup of chronic disorders is important. The reduction of
expenditure is of great of importance in health care all
over the world.
In conclusion, even with these limitations, our
present study was able to detect NLR as being higher in
AR patients compared to those without rejection, which
might indicate an increased risk of AR associated with
higher NLR levels. The findings from this retrospective
study must be confirmed. Larger, prospective, controlled,
and long-term follow-up studies are needed to further
determine the sensitivity, specificity, and predictability
of this inexpensive, convenient test in the early diagnosis
of acute graft rejection. Further validation and feasibility
studies are required before it can be considered for
routine clinical use.
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